Â
Press Release
Â
Â
For Immediate Release
Contact: Dan Gordon , 617-651-0841
August 4, 2021
**Vaccines for Migrants a Positive Step**
**WASHINGTON, D.C.**- The Biden administration is preparing to offer
vaccines to migrants in custody along the U.S.-Mexico border, The
Washington Post reports
.
Under the new plan, the Department of Homeland Security would
vaccinate migrants soon after they enter the U.S. and before they are
processed by U.S. Customs and Border Protection. Previously, only a
limited number of migrants detained in longer-term facilities had
received the vaccine.Â
Migrants who are turned back to Mexico under the pandemic-era use of
Title 42 will not get the vaccine initially, according to the report.
"The decision to vaccinate migrants who enter the U.S. is a positive
step," said
**Ali Noorani, President and CEO of the National Immigration Forum**.
****"Moving forward, the administration should expand vaccine access to
migrants expelled under Title 42. Doing so will benefit communities on
both sides of the border and brings us closer to reopening the border to
more trade, tourism and legal immigration.
"This federal plan on vaccines builds on existing health and safety
efforts on the ground. Border communities, faith groups and nonprofits
are helping ensure
that asylum-seekers who enter the country are tested for COVID and
properly quarantined should they test positive. This approach supports
public health and safety for migrants and U.S. citizens alike."
###
Â
Â
**Follow Us**
Â
[link removed]
[link removed]
[link removed]
[link removed]
Â
Â
Â
The
**Only in America** podcast brings you to the people behind our
nation's immigration debate.
Â
Listen now on:
Â
**iTunes**
,
**Stitcher**
,
**Spotify** ,
and **more.**
Â
Â
National Immigration Forum
10 G Street NE, Suite 500
Washington, DC 20002
www.immigrationforum.org
Â
Unsubscribe from Press Releases oropt-out from all
Forum emails.
Â
                       Â
     Â
_________________
Sent to
[email protected]
Unsubscribe:
[link removed]
National Immigration Forum, 10 G St NE, Suite 500, Washington, D.C. 20002, United States